Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.
This report contains market size and forecasts of Monoclonal Antibodies Sterile Injectable Drugs in global, including the following market information:
Global Monoclonal Antibodies Sterile Injectable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Monoclonal Antibodies Sterile Injectable Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Monoclonal Antibodies Sterile Injectable Drugs companies in 2021 (%)
The global Monoclonal Antibodies Sterile Injectable Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
In Vivo Production Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Monoclonal Antibodies Sterile Injectable Drugs include Merck, Pfizer, Abbott, GlaxoSmithKline, AstraZeneca, Novartis, ​​Bayer, Amgen and Bristol Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoclonal Antibodies Sterile Injectable Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal Antibodies Sterile Injectable Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Monoclonal Antibodies Sterile Injectable Drugs Market Segment Percentages, by Type, 2021 (%)
In Vivo Production Drugs
In Vitro Production Drugs
Global Monoclonal Antibodies Sterile Injectable Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Monoclonal Antibodies Sterile Injectable Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Monoclonal Antibodies Sterile Injectable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Monoclonal Antibodies Sterile Injectable Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal Antibodies Sterile Injectable Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Monoclonal Antibodies Sterile Injectable Drugs revenues share in global market, 2021 (%)
Key companies Monoclonal Antibodies Sterile Injectable Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Monoclonal Antibodies Sterile Injectable Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Abbott
GlaxoSmithKline
AstraZeneca
Novartis
​​Bayer
Amgen
Bristol Myers Squibb
Johnson&Johnson
Roche
Sanofi